About Cello Therapeutics

Cello Therapeutics, Inc. (Cello) was founded in April 2016 and specializes in the development of nanoparticles for cancer treatment. Their nanoparticles are composed of FDA-approved cancer drugs loaded within a biocompatible polymer core. These nanoparticles are then coated with natural red blood cell membrane, a recent breakthrough technology in the field of nanomedicine. Appearing as red blood cells to the body, these membrane-coated nanoparticles are able to avoid evoking an immune response wView more